000

KUKJE PHARMA

No trades
See on Supercharts
Market capitalization
‪114.09 B‬KRW
‪−8.42 B‬KRW
‪135.37 B‬KRW
‪11.76 M‬
Beta (1Y)
0.72
Employees (FY)
254
Revenue / Employee (1Y)
‪409.32 K‬KRW
Net income / Employee (1Y)
‪−25.44 K‬KRW

About KUKJE PHARMA


Headquarters
Seongnam-si
Founded
1959
ISIN
KR7002720001
FIGI
BBG000BDQM56
KUKJE PHARMA Co. Ltd. engages in the manufacture, sale, and distribution of pharmaceutical, cosmetics, and healthcare products. Its products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, antibiotics, and antifungal and antiviral agents. The company was founded on July 27, 1959 and is headquartered in Seongnam, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 002720 is 5,990 KRW — it has increased by 8.91% in the past 24 hours. Watch KUKJE PHARMA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KUKJE PHARMA stocks are traded under the ticker 002720.
002720 stock has risen by 6.77% compared to the previous week, the month change is a 7.54% rise, over the last year KUKJE PHARMA has showed a 9.11% increase.
002720 reached its all-time high on Aug 20, 2020 with the price of 14,990 KRW, and its all-time low was 460 KRW and was reached on May 14, 2004. View more price dynamics on 002720 chart.
See other stocks reaching their highest and lowest prices.
002720 stock is 17.77% volatile and has beta coefficient of 0.72. Track KUKJE PHARMA stock price on the chart and check out the list of the most volatile stocks — is KUKJE PHARMA there?
Today KUKJE PHARMA has the market capitalization of ‪111.99 B‬, it has increased by 1.62% over the last week.
Yes, you can track KUKJE PHARMA financials in yearly and quarterly reports right on TradingView.
002720 net income for the last quarter is ‪597.39 M‬ KRW, while the quarter before that showed ‪2.75 B‬ KRW of net income which accounts for −78.27% change. Track more KUKJE PHARMA financial stats to get the full picture.
As of Nov 13, 2024, the company has 254.00 employees. See our rating of the largest employees — is KUKJE PHARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KUKJE PHARMA EBITDA is ‪3.02 B‬ KRW, and current EBITDA margin is 1.64%. See more stats in KUKJE PHARMA financial statements.
Like other stocks, 002720 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KUKJE PHARMA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KUKJE PHARMA technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KUKJE PHARMA stock shows the strong buy signal. See more of KUKJE PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.